Individualizing Glaucoma Treatment: Understanding How to Utilize Traditional and Novel Agents is organized by Evolve Medical Education (EME) LLC .
Release Date: Dec 03, 2021
Expiry Date: Nov 28, 2024
Learning Objectives:
Upon completion of this activity, the participant should be able to:
• Describe the mechanisms of action of novel therapeutics and classes of drugs for ocular hypertension (OHT) and primary open angle glaucoma (POAG)
• Interpret the challenges and limitations associated with currently available pharmacologic treatment options for OHT and POAG
• Evaluate monotherapy and combination regimens and compare which option is most likely to achieve each individual patient’s goal IOP
• Compare and assess the efficacy of novel therapeutics with traditional prostaglandins
Accreditation and Designation Statement:
This educational activity is provided by Evolve Medical Education LLC (Evolve).
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved